{"nctId":"NCT01402102","briefTitle":"A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia","startDateStruct":{"date":"2010-07"},"conditions":["Hyperlipidemia"],"count":60,"armGroups":[{"label":"Aged garlic powder","type":"EXPERIMENTAL","interventionNames":["Dietary Supplement: Aged garlic powder"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo powder"]}],"interventions":[{"name":"Aged garlic powder","otherNames":[]},{"name":"Placebo powder","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Mild hypercholesterolemic subjects aged from 20 to 80 years\n* had no received lipid-lowering drugs for at least 3 months prior to the recruitment\n\nExclusion Criteria:\n\n* self-reported pregnancy,lactation\n* prevalent heart disease,cancer,renal disorder, or diabetes mellitus, and use of lipid or antihypertensive medications","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol)","description":"LDL-C(Low Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"150.6","spread":"14.1"},{"groupId":"OG001","value":"150.1","spread":"15.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"155.8","spread":"21.9"},{"groupId":"OG001","value":"156.3","spread":"29.8"}]}]}]},{"type":"SECONDARY","title":"Changes in HDL-Cholesterol(High Density Lipoprotein - Cholesterol)","description":"HDL-cholesterol(High Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.86","spread":"9.40"},{"groupId":"OG001","value":"50.81","spread":"9.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.36","spread":"8.85"},{"groupId":"OG001","value":"50.48","spread":"9.76"}]}]}]},{"type":"SECONDARY","title":"Changes in Triglycerides","description":"Triglyceride was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"139.79","spread":"54.55"},{"groupId":"OG001","value":"124.11","spread":"47.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120.21","spread":"63.61"},{"groupId":"OG001","value":"128.11","spread":"65.50"}]}]}]},{"type":"SECONDARY","title":"Changes in Total Cholesterol","description":"Total cholesterol was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"241.07","spread":"23.97"},{"groupId":"OG001","value":"228.93","spread":"20.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"233.50","spread":"24.63"},{"groupId":"OG001","value":"227.33","spread":"32.51"}]}]}]},{"type":"SECONDARY","title":"Changes in Apo-A1(Apolipoprotein A1)","description":"Apo-A1(Apolipoprotein A1) was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.48","spread":"0.21"},{"groupId":"OG001","value":"1.43","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.41","spread":"0.19"},{"groupId":"OG001","value":"1.39","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Changes in Apo-B(Apolipoprotein B)","description":"Apo-B(Apolipoprotein B) was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.21","spread":"0.13"},{"groupId":"OG001","value":"1.03","spread":"0.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.07","spread":"0.12"},{"groupId":"OG001","value":"1.01","spread":"0.19"}]}]}]},{"type":"SECONDARY","title":"Changes in FFA(Free Fatty Acid)","description":"FFA(free fatty acid) was measured in study visit 1(0 week) and visit 3(12 week).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"570.25","spread":"193.02"},{"groupId":"OG001","value":"554.04","spread":"179.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"618.14","spread":"184.78"},{"groupId":"OG001","value":"523.93","spread":"222.93"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}